Shiliang Hu
机构：AstraZeneca (South Korea), Alexion Pharmaceuticals (United States)
发表论文 5 篇 · 总被引 153 次 · h-index 2
代表论文
- Plastome organization and evolution of chloroplast genes in Cardamine species adapted to contrasting habitats (2015 · BMC Genomics · 被引 133)
- A Comprehensive Study of the Effects by Sequence Truncation within Inverted Terminal Repeats (ITRs) on the Productivity, Genome Packaging, and Potency of AAV Vectors (2024 · Microorganisms · 被引 16)
- Phylogeny and chloroplast evolution in Brassicaceae (2016 · Unitn-eprints PhD (University of Trento) · 被引 2)
- Liver-Targeted AAV-DJ-hCBS Therapy Achieves Long-Term Correction of Metabolic Imbalance in CBS-Deficient Mice (2026 · International Journal of Molecular Sciences)